Blockchain Registration Transaction Record

innoscripta Soars in H1 2026: Revenue Up 43%, Global Expansion on Track

innoscripta SE reports H1 2026 revenue up 43% to EUR 63.1M, EBIT up 49% to EUR 36.4M, and confirms 2026 guidance of EUR 140M revenue. International expansion into France, UK, US.

This news matters because innoscripta's robust growth and successful international expansion indicate a rising demand for R&D tax credit software solutions globally. For businesses engaged in R&D, innoscripta's Clusterix platform offers a way to streamline and maximize tax benefits, potentially freeing up capital for further innovation. The company's entry into new markets like the US and UK could provide local companies with more accessible and efficient tools to manage their R&D activities, ultimately fostering innovation and economic growth. Additionally, innoscripta's strong financial performance and confirmed guidance make it a notable player for investors in the SaaS and fintech sectors, signaling a healthy market for R&D tax incentivization services.